JelikaLite is a clinical stage medical technology company dedicated to developing non-invasive, wearable medical devices for children with autism spectrum disorders (ASD). Their core mission is to address the unmet needs in developmental pediatric disorders through innovative neuromodulation platforms. The lead product combines infrared light, sensors, and an AI personalization platform to promote brain health and improve communication, social interactions, and focus in children with ASD.
JelikaLite has made significant strides in the field of pediatric neuromodulation, positioning itself as a pioneer in non-invasive therapy for autism. Their novel approach has garnered attention for its potential to transform the lives of children with ASD, offering a promising alternative to existing inadequate solutions. The company's impact is underscored by its commitment to advancing brain health through cutting-edge technology and personalized treatment plans.
